Pfizer COVID antiviral: Dozens of companies to start making pill FOX13
Generic drugmakers across a dozen countries in Asia, the Caribbean, the Middle East and Eastern Europe will begin producing either the raw ingredients for the Pfizer drug or the pill itself. Among the companies offered a license was one in Ukraine, which has not yet been able to confirm it can participate.
Gore estimated that some generic companies might be ready to submit their drugs for regulatory approval later this year, with some supplies available in 2023.COVID-19 Many health experts welcomed the deal but pointed out that gaps remain. Some countries that have suffered devastating COVID-19 outbreaks, like Brazil, for example, are excluded from the deal. Under the terms of the agreements, Brazilian companies can manufacture the Pfizer pill, but the generic version will not be available for sale there.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Three Covid-related deaths and 2,054 casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,266.
Read more »
Pfizer-BioNTech will seek authorization for second COVID booster for older adultsPfizer is planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people 65 and older.
Read more »
Pfizer Seeking OK for 4th COVID Dose for Seniors: AP SourceDrugmaker Pfizer is expected to request authorization this week for an additional COVID booster dose for those over 65, which would add a fourth dose to the regimen in an effort to provide maximum protection to a population hit hardest by the pandemic
Read more »
Pfizer asks US to allow 4th COVID vaccine dose for seniorsPfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors.
Read more »
Pfizer Reportedly Set To Request Authorization For Second Covid Booster Shot For SeniorsPfizer-BioNTech will soon request FDA emergency authorization for a second Covid booster shot for people 65 and older, a group for which the agency has previously been quick to approve new shots, the Washington Post reported.
Read more »
Pfizer asks US to authorize 4th COVID-19 vaccine dose for seniorsPfizer and its partner BioNTech asked U.S. regulators Tuesday to authorize an additional booster dose of their COVID-19 vaccine for seniors, saying data from Israel suggests older adults would benefit.
Read more »